J. Athene Lane

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial”.

Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial

PharmacoEconomics(2022)10.1007/s40273-022-01191-1

N/A

0.449DataRank · unranked

19 citations

Sabina Sanghera, Richard M Martin, Roman Gulati, Fredrik Wiklund, Eleanor Walsh +8 more

Specificity of a polygenic score for aggressive prostate cancer

medRxiv(2025)10.1101/2025.01.23.25321041

N/A

0.165DataRank · unranked

2 citations

George Xu, Roshan Karunamuni, Charles A. Brunette, Morgan Danowski, Craig C. Teerlink +21 more

Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer

Prostate Cancer and Prostatic Diseases(2021)10.1038/s41391-020-00311-2

N/A

0DataRank · unranked

25 citations

Roshan Karunamuni, APCB BioResource (Australian Prostate Cancer BioResource), Canary PASS Investigators, Minh‐Phuong Huynh‐Le, Chun Chieh Fan +63 more

Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT

Efficacy and Mechanism Evaluation(2021)10.3310/eme08190

N/A

0DataRank · unranked

8 citations

Nicholas Turner, Beth Howden, Lina Jarutyt, Shona Clegg, Ian B. Malone +16 more